Terumo ends Boston pact and goes direct with vascular device sales:
This article was originally published in Clinica
Terumo Medical, the US arm of Japanese group Terumo, is to take on the sales and marketing of its interventional vascular products in the US and Latin America, terminating a 15-year distribution partnership with Boston Scientific as a result. Somerset, New Jersey-based Terumo Medical's interventional systems business has undergone a four-fold expansion of its direct sales force in line with the new strategy, which takes effect in April 2006. Terumo already uses its own sales team for its line of peripheral embolisation products, including Bead Block microspheres and Progreat microcatheters.